ALMR
Alamar Biosciences, Inc.
There isn't enough reported data to score ALMR yet.
ALMR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate ALMR's fundamentals.
ALMR PE Valuation
ALMR has no meaningful PE right now: it lost money over the past year.
ALMR Forward outlook
There aren't enough analyst estimates for ALMR to show an outlook.
ALMR Earnings Per Share
ALMR Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -45% | N/A |
| Q2 2026 | -46% | N/A |
| Q1 2026 | -47% | N/A |
ALMR Free Cash Flow
ALMR Net Leverage
ALMR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ALMR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.8 | Neutral |
| Stochastic | 43.0 | Neutral |
ALMR's weekly RSI is 61 (neutral) and its Stochastic is 43 (neutral).
ALMR PE vs Healthcare Sector
ALMR has no meaningful PE right now: it lost money over the past year.
ALMR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.9 | 6.4% above |
| 20 week MA | $29.5 | 7.6% above |
ALMR is in an uptrend: it's above all two of its weekly moving averages, and 7.6% above its 20-week average.
ALMR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $22.0 | $31.8 | +44% |
It's up 44% so far in 2026.